Drug intelligence / Profile preview

MMI-467

Development stage: Preclinical
Administration: Topical

Overview

MMI-467 is an investigational drug developed for the treatment of distal subungual onychomycosis, a common fungal infection affecting the toenails and fingernails. The specific mechanism of action, chemical class, and molecular target for MMI-467 are not detailed in publicly available sources. Its development status and additional clinical information remain limited[1].

Beyond the preview

Go deeper on MMI-467.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MMI-467.

Explore the full profile